Followers | 18 |
Posts | 179 |
Boards Moderated | 0 |
Alias Born | 06/15/2021 |
Wednesday, November 03, 2021 3:38:57 PM
Do you happen to know what the market capitalization is right now for GRPS? That's ok, I have it right here:
OS 1,277,089,842 x PPS .01 = $12,770,898.42
What part of GRPS right now is worth $13 million? Are you aware of a $13 million contract that hasn't been made public? Are you aware of $13 million in GRPS assets not outlined in public filings? Are you aware of a GRPS patent that someone tried to purchase for $13 million? No? Well, then, I would be happy with that penny, because according to the current financials, this company isn't worth the penny it's trading at, technically.
Now, intrinsically, the company is worth (in my opinion) north of $1 Billion over the next few years. I've done my fair share of potential future cash flow calculations based on a series of variables, many of which are constantly changing. However, the implied assumptions (supported by facts) help me get to that number. It's possible, based on the demand of the industry ($1 trillion) and it's current CAGR (roughly 12.4% through 2028) that my $1 Billion estimate is way low.
There is enough information out there (through formal DD) to suggest that most products in this space DO NOT have near the efficacy that the GRPS products have. If the CBD market (alone) is bringing in Billions every year (and is expected to be one of the fastest growing markets in our lifetime), that means there is a solid market for the stuff. So people are very willing to pay for these types of products already, and many of them don't even have the appropriate amounts of specific and rare cannabinoids necessary to produce the desired results! What's out there right now is, at best, a nice try. There are some folks who have attempted to exploit the CBD craze and cash in on it with a sub-par product (many of which were tested to show very little or NO CBD at all).
Why is this exciting? It's exciting because when the GRPS superior products formally break onto the scene, people will choose the superior product, because it works better than whatever they were already willing to pay for.
Pending Government contracts will properly solidify GRPS product legitimacy. I've dealt with Government contracts in my day. Believe me when I say they don't just say "sure" to anything. There is a vetting process and if they put ink on a contract with GRPS, it's because everything checked out.
Should a Government contract be announced, it will likely send this stock quite quickly to the .10 range (less than two full trading days I would estimate). I've been part of stocks that went from .30 to $3.00 in two days on far less of an announcement. Unfortunately I cannot calculate a very important variable for this, which is the free will of investors to sell on the news. The amount of resistance on the ask will play a significant role in how high the PPS will be able to go, until that resistance has subsided. Then, eventually, shares will have traded hands from "shareholders" to "stakeholders" and it's off to the races (big boards).
Institutional investors need to see ink. Without ink on a contract, it's all just a "good idea". So if/when that ink is revealed to the public, those institutional investors will have been given the green light to pull the trigger on the purchase of the stock. Will they end up paying a premium as a result of waiting? Sure they will. But they will gladly pay more if it means substantially reducing their risk.
Just to recap - there is no sense in how this stock is trading at .01 right now unless you can show me $13 million in revenue or assets (technically). However, focusing on the technical side of things would be ill advised in my opinion, as the intrinsic value is where the savvy investor will reap the largest rewards.
- Dr. Bond's Gummies (available now)
- "PLEX" line of Nutraceuticals (likely available around 1 Jan 22)
- Pending Government contracts
- Possible professional sports team affiliation
- Pending contract for 800-1000 Physician Network
- Stem Cell Division
- Veterinary Division
- No Reverse Split clause
- No Dilution
- Brilliant share structure (for OTC)
- PINK Current
.10 coming.
Oh and I forgot about this...
Here you go. Enjoy the read.
https://www.justice.gov/usao-sdny/pr/stock-trader-arrested-and-charged-securities-fraud-using-his-twitter-account-operate
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM